title: Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome.
authors.affiliation: Division d'Hématologie et Clinique d'Obstétrique, Hôpital Cantonal Universitaire de Genève, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Beris
authors.forename: R
authors.initials: R
authors.lastname: Darbellay
authors.forename: P
authors.initials: P
authors.lastname: Extermann
mesh_terms: D000032:Abortion, Therapeutic / Q000523:psychology / Q000706:statistics & numerical data; D001483:Base Sequence; D004252:DNA Mutational Analysis; D004198:Disease Susceptibility / Q000208:ethnology; D004200:Diseases in Twins / Q000175:diagnosis / Q000235:genetics; D005006:Ethnicity / Q000235:genetics; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005315:Fetal Diseases / Q000175:diagnosis / Q000235:genetics / Q000517:prevention & control; D005544:Forecasting; D006580:Genetic Carrier Screening; D005817:Genetic Counseling; D014943:Global Health; D005914:Globins / Q000235:genetics*; D006455:Hemoglobins, Abnormal / Q000235:genetics*; D006801:Humans; D015160:Hydrops Fetalis / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D008969:Molecular Sequence Data; D010342:Patient Acceptance of Health Care; D011247:Pregnancy; D018607:Pregnancy Reduction, Multifetal; D011272:Pregnancy, Multiple; D011296:Prenatal Diagnosis; D015397:Program Evaluation; D012306:Risk; D017085:alpha-Thalassemia / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D017086:beta-Thalassemia / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*
chemical_list: D006455:Hemoglobins, Abnormal; D005914:Globins; C030448:hemoglobin Bart's